glp-1 for diabetes type 2 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Understanding GLP-1 in Diabetes

Stacking GLP-1 agonists amplifies side effects without proportional benefit

Retatrutide is a novel triple receptor agonist (GLP-1, GIP, and glucagon receptor) currently under Phase III clinical investigation for metabolic research applications

Oestrogen helps regulate body temperature and promotes the effects of sleep-inducing hormones like melatonin

Check out a few of the many people that we have helped reach their ideal weight goals over the years

Nature.com.

and GIP receptors have also been demonstrated to activate phosphoinositide 3-kinase (PI3K) and its downstream effector Akt, which modulates mitochondrial function, metabolism, and cell survival